The effect of irritable bowel syndrome on health-related quality of life and health care expenditures.
about
Profile of rifaximin and its potential in the treatment of irritable bowel syndromeFood allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivityTianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open-label, non-inferiority, randomized controlled studyNeuroimaging the brain-gut axis in patients with irritable bowel syndromeThe combination of oligo- and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: Results of a randomised, placebo-controlled, double-blind, parallel group, multicentre clinical trial.A preliminary evaluation of comparative effectiveness of riluzole in therapeutic regimen for irritable bowel syndrome.Role of antispasmodics in the treatment of irritable bowel syndrome.Irritable Bowel Syndrome: Clinical Manifestations, Dietary Influences, and Management.Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndromeLow-FODMAP Diet for Irritable Bowel Syndrome: Is It Ready for Prime Time?Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome.Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model.Functional urological disorders: a sensitized defence response in the bladder-gut-brain axis.A school-based study with Rome III criteria on the prevalence of functional gastrointestinal disorders in Chinese college and university students.Mechanisms and effectiveness of prebiotics in modifying the gastrointestinal microbiota for the management of digestive disorders.Bacterial infections in childhood: A risk factor for gastrointestinal and other diseases?The epidemiology of functional gastrointestinal disorders in Mexico: a population-based studyIrritable Bowel Syndrome Is Associated with an Increased Risk of Dementia: A Nationwide Population-Based Study.Knowledge, attitudes, and practices of primary care physicians about irritable bowel syndrome in Northern Saudi ArabiaIrritable Bowel Syndrome Increases the Risk of Epilepsy: A Population-Based Study.Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome.Age-related symptom and life quality changes in women with irritable bowel syndromeEfficacy of otilonium bromide in irritable bowel syndrome: a pooled analysisSafety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea.Economics of medically unexplained symptoms: a systematic review of the literature.Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis.A four-country comparison of healthcare systems, implementation of diagnostic criteria, and treatment availability for functional gastrointestinal disorders: a report of the Rome Foundation Working Team on cross-cultural, multinational research.Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers' diarrhoea.Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies.Smoking in Irritable Bowel Syndrome: A Systematic Review.British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update).Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.Postinfectious irritable bowel syndrome after travelers' diarrhea--a cohort study.Point of Care Ultrasound Accurately Distinguishes Inflammatory from Noninflammatory Disease in Patients Presenting with Abdominal Pain and Diarrhea.Functional Gastrointestinal Disorders in Young Military Men.Linaclotide activates guanylate cyclase-C/cGMP/protein kinase-II-dependent trafficking of CFTR in the intestine.Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review.Editorial: subgroups in irritable bowel syndrome-more than just diarrhoea and constipation? Authors' reply.A case-control study of childhood trauma in the development of irritable bowel syndrome.Effect of transcranial magnetic stimulation on rectal sensitivity in irritable bowel syndrome: a randomized, placebo-controlled pilot study.
P2860
Q26829363-C30E9169-E2AE-4823-9D7F-8C62244F91EFQ28087731-AB6335D4-7AF5-468C-8937-F09CF22599A6Q28268467-EDEBA1E0-6E08-43C5-828D-EA493282E737Q31093698-CCA61A05-9353-4CA8-84A9-E4FF02A266ABQ33468382-DE1ADD12-0770-45AE-B547-93BAEE0F1951Q33628957-CE1A2223-FAAE-494B-9D9F-000E78714F53Q33661077-EF105AA1-0503-46D3-9C71-830B2C47A814Q33855973-79E219F2-0CEB-4AFC-B826-98DF851A59E6Q33917011-7AB77701-D35D-429E-84D9-9353F9C36A7DQ34042481-1AF99A6E-A16E-40A2-BD26-A23BD4988E2BQ34420107-65C627B6-7B95-4B2C-B177-D4C35E61C000Q34449503-AD15787A-1403-4EE3-BD1F-9D51D0BF9A0BQ34546729-0C090524-523F-4EF2-BA89-3E61F655791EQ34562714-359F3C50-E7A4-4CF9-929C-C694AD843292Q34726491-29F26EE4-6A96-4712-8834-61D13E1EAAF5Q35044211-5DA05E49-4BCD-4F7A-81AD-65E060286CAAQ35855576-8348FC06-DA4A-45C8-911D-CB3643A0446EQ35885500-41A15CA3-D543-473D-BF25-835C0D2288CFQ36020927-42AE1F25-3343-4D01-B333-24011914AD45Q36194938-40598B1C-0768-4F2D-B9A9-C67640F8F912Q36450117-D970C532-5AD1-4842-B1D5-77872340F944Q36529141-EC77BCC1-6010-409C-AE76-4D1D25901236Q37638787-F0A5A279-BEF0-4626-BCC3-C4A2E827AAF4Q37654528-3D264898-6878-4859-9AF6-4F508F35135CQ38029474-EA78F785-4F0F-4365-92D6-0B2178785B8CQ38209378-2D1C7B6D-3CA9-4BA6-8B74-A9969D905670Q38236420-D3B65246-7E64-4536-BE13-C0D42187DA54Q38420105-2953BAC3-EE0C-481A-9D75-EA89E8C49038Q38625807-005EB852-CACE-465C-8C81-F1ABF97F23DAQ38727941-700B5792-C579-4D1E-9F89-66E87B1B24F2Q38855986-B59448B1-EAE6-490F-96E9-46C69675B9C6Q39018445-804D9499-7D0E-48F8-BAD7-650F6C820DA4Q39441319-2C2EC232-312F-4685-A83C-2CFA357559DCQ39571804-186929B0-79A3-469A-88E9-A8501DCB17E2Q41729414-C1988C84-E0B1-46D4-BFDC-85D7D00D08DDQ42202020-CB6C757B-14D8-4A54-8A29-869436528608Q45332660-99C0F50A-CF25-4E5B-B186-3C2E39DB0DBDQ48112854-86A706DC-9849-4ACB-8A7D-FDCB93DCFD67Q48783040-269F3A31-6B5E-49F8-86E6-1C5C32ADCE2BQ48939259-EE342A71-9826-4383-A481-E01B820E3206
P2860
The effect of irritable bowel syndrome on health-related quality of life and health care expenditures.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The effect of irritable bowel ...... and health care expenditures.
@en
The effect of irritable bowel ...... and health care expenditures.
@nl
type
label
The effect of irritable bowel ...... and health care expenditures.
@en
The effect of irritable bowel ...... and health care expenditures.
@nl
prefLabel
The effect of irritable bowel ...... and health care expenditures.
@en
The effect of irritable bowel ...... and health care expenditures.
@nl
P1476
The effect of irritable bowel ...... and health care expenditures.
@en
P2093
Brennan M R Spiegel
Nikhil Agarwal
P356
10.1016/J.GTC.2010.12.013
P577
2011-03-01T00:00:00Z